Showing 18,581 - 18,600 results of 21,342 for search '(( ((significant decrease) OR (significant increase)) decrease ) OR ( significant a decrease ))', query time: 0.47s Refine Results
  1. 18581

    Behavioral characterization of prenatal nicotine exposure (PNE) and control mice. by Rodrigo Vidal (4177060)

    Published 2025
    “…Bottom, PNE mice showed a decreased recognition index percentage compared to control mice (PNE: 24.00 ± 1.03%, n = 6; Control: 53.17 ± 4.09%, n = 6), t = 6,921 df = 10, p < 0,0001. …”
  2. 18582

    Data Sheet 1_Synergistic effect of regorafenib with aminoglycosides in ferroptosis-mediated liver injury.docx by Maha Raja Dahar (21716714)

    Published 2025
    “…The in vitro assay results validate the enhanced levels of cellular iron, lipid peroxidation, reactive oxygen species, and lactate dehydrogenase release, indicating enhanced toxicity. In contrast, it decreased the cell viability ratio, glutathione level, and integrity of the mitochondrial membrane. …”
  3. 18583

    Impact of carbon and nitrogen assimilation in Sargassum fusiforme (Harvey) Setchell due to marine heatwave under global warming - data by Xingda Sheng (20582644)

    Published 2025
    “…Morphologically, heatwave stress damaged the thylakoid structure and reduces the photosynthetic efficiency of algae, and accumulated NADPH, ATP, and α-ketoglutarate significantly, resulting in decreased content of mannitol, the photosynthetic product. …”
  4. 18584

    Image 6_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  5. 18585

    Image 3_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  6. 18586

    Image 1_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.tif by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  7. 18587

    Table 2_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  8. 18588

    Table 4_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  9. 18589

    Table 3_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  10. 18590

    Table 1_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  11. 18591

    Table 5_Burden of pulmonary arterial hypertension in children globally, regionally, and nationally (1990–2021): results from the global burden of disease study.docx by Lili Deng (152262)

    Published 2025
    “…Significantly, reductions were observed in both mortality and disability-adjusted life years (DALYs) associated with pediatric PAH, with mortality decreasing by 57.66% and DALYs by 63.59% over the study period, indicating progress in mitigating the disease burden. …”
  12. 18592

    Light avoidance requires the cGMP-dependent pathway in <i>P</i>. <i>pacificus</i>. by Kenichi Nakayama (2354653)

    Published 2024
    “…These mutants had decreased light-induced avoidance response. (B) List of predicted causal genes. …”
  13. 18593

    Table 4_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xls by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  14. 18594

    Table 2_Identification of metabolic pathways modulated by GAM and NGAM in the inhibition of Staphylococcus aureus biofilm formation.xlsx by Amirmohammad Afsharnia (22569827)

    Published 2025
    “…<p>The prevalence of antibiotic-resistant bacterial strains, particularly Staphylococcus aureus, poses a significant threat to global health. The ability of S. aureus to form biofilms reduces the efficacy of antibiotics. …”
  15. 18595

    Image 1_Identification of metabolic pathways modulated by GAM and NGAM in the inhibition of Staphylococcus aureus biofilm formation.jpeg by Amirmohammad Afsharnia (22569827)

    Published 2025
    “…<p>The prevalence of antibiotic-resistant bacterial strains, particularly Staphylococcus aureus, poses a significant threat to global health. The ability of S. aureus to form biofilms reduces the efficacy of antibiotics. …”
  16. 18596

    Data Sheet 1_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.doc by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  17. 18597

    Table 2_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  18. 18598

    Table 7_Pachymic acid alleviates metabolic dysfunction-associated steatotic liver disease by inhibiting ferroptosis through PPARα.xlsx by Guilin Ren (18720749)

    Published 2025
    “…Introduction<p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by excessive lipid deposition in hepatocytes without a history of significant alcohol consumption. Pachymic acid (Pac), a bioactive triterpenoid from Poria cocos, has shown promise in treating MASLD due to its antioxidant and anti-inflammatory capabilities. …”
  19. 18599

    Table 1_Identification of metabolic pathways modulated by GAM and NGAM in the inhibition of Staphylococcus aureus biofilm formation.xlsx by Amirmohammad Afsharnia (22569827)

    Published 2025
    “…<p>The prevalence of antibiotic-resistant bacterial strains, particularly Staphylococcus aureus, poses a significant threat to global health. The ability of S. aureus to form biofilms reduces the efficacy of antibiotics. …”
  20. 18600

    original data.xlsx by Peng Shen (20145351)

    Published 2024
    “…<b>Research Results</b>: The results showed that the levels of inflammatory factors significantly decreased in the blood purification treatment group after treatment, with a notable reduction in hospitalization and ICU stay duration compared to the conventional treatment group. …”